journal article·2024-11Open access

TRIM56 Modulates YBX1 Degradation to Ameliorate ZBP1‐Mediated Neuronal PANoptosis in Spinal Cord Injury

Junsheng Lou, Yiting Mao, Wu Jiang, Honghao Shen, Yunpeng Fan, Qing Yu, Conghui Zhou, Ziyao Wei, Kailiang Zhou, Mengran Jin, Junsong Wu

Advanced Science· Volume 11· Issue 42

Abstract

Abstract Spinal cord injury (SCI) is a severe injury to the central nervous system, and its treatment is always a major medical challenge. Proinflammatory cell death is considered an important factor affecting neuroinflammation and the prognosis after injury. PANoptosis, a newly discovered type of proinflammatory cell death, regulates the activation of executioner molecules of apoptosis, pyroptosis and necroptosis through the PANoptosome, providing a new target for therapeutic intervention after SCI. However, its role and regulatory mechanism in SCI are not yet elucidated. Here, based on proteomic data, YBX1 expression is significantly increased in neurons after SCI. Guided by RIP‐seq, subsequent experiments reveal that YBX1 promotes ZBP1 expression by stabilizing the Zbp1 mRNA, thereby aggravating ZBP1‐mediated PANoptosis. Furthermore, the E3 ubiquitin ligase TRIM56 is identified as an endogenous inhibitor of YBX1 via molecular docking and IP/MS analysis. Mechanistically, TRIM56 bound to YBX1 and promoted its ubiquitination, thereby accelerating its degradation. Taken together, these findings reveal a novel function of YBX1 in regulating ZBP1‐mediated PANoptosis in the pathogenesis of SCI and verified that TRIM56 functions as an endogenous inhibitor to promote the ubiquitin‐proteasomal degradation of YBX1, providing new insights into SCI treatment strategies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spinal Cord Injury Research · Inflammasome and immune disorders · Toxoplasma gondii Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedic Surgery The First Affiliated Hospital Zhejiang University School of Medicine No. 79 Qingchun Road Hangzhou 310003 China

Obstetrics and Gynecology Hospital Institute of Reproduction and Development Fudan University Shanghai 200090 China

Department of Orthopeadics Affiliated Hangzhou First People's Hospital School of Medicine Westlake University No. 261 Huansha Road Hangzhou 310006 China

Department of Critical Care Medicine the Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou 310009 China

Department of Orthopeadics The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou 325027 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province

References (58)

Show source-provided references
1. 10.1007/s00018-022-04261-x10.1007/s00018-022-04261-x ↗
2. 10.1038/nrdp.2017.1810.1038/nrdp.2017.18 ↗
3. 10.1038/s41467-023-39745-210.1038/s41467-023-39745-2 ↗
4. 10.1126/science.aam792810.1126/science.aam7928 ↗
5. 10.1186/s12974-021-02337-210.1186/s12974-021-02337-2 ↗
6. 10.1016/j.freeradbiomed.2023.08.02610.1016/j.freeradbiomed.2023.08.026 ↗
7. 10.1016/j.redox.2023.10287110.1016/j.redox.2023.102871 ↗
8. 10.1186/s12951-022-01724-y10.1186/s12951-022-01724-y ↗
9. 10.1016/j.molmed.2023.10.00110.1016/j.molmed.2023.10.001 ↗
10. 10.1038/s41419-023-06370-210.1038/s41419-023-06370-2 ↗
11. 10.1016/j.tips.2024.06.00210.1016/j.tips.2024.06.002 ↗
12. 10.1038/s41401-022-01010-510.1038/s41401-022-01010-5 ↗
13. 10.7150/thno.9181410.7150/thno.91814 ↗
14. 10.1182/blood.202000967610.1182/blood.2020009676 ↗
15. 10.1016/j.semcancer.2022.01.01010.1016/j.semcancer.2022.01.010 ↗
16. 10.15252/embj.202211176210.15252/embj.2022111762 ↗
17. 10.1073/pnas.221513212010.1073/pnas.2215132120 ↗
18. 10.1161/CIRCRESAHA.122.32184910.1161/CIRCRESAHA.122.321849 ↗
19. 10.1002/glia.2399210.1002/glia.23992 ↗
20. 10.1038/s41418-022-01089-710.1038/s41418-022-01089-7 ↗
21. 10.1172/JCI16614910.1172/JCI166149 ↗
22. 10.1080/15548627.2022.216442710.1080/15548627.2022.2164427 ↗
23. 10.1016/j.celrep.2023.11230610.1016/j.celrep.2023.112306 ↗
24. 10.1038/s41467-023-42040-910.1038/s41467-023-42040-9 ↗
25. 10.1016/j.freeradbiomed.2023.12.02010.1016/j.freeradbiomed.2023.12.020 ↗
26. 10.1126/sciimmunol.abo629410.1126/sciimmunol.abo6294 ↗
27. 10.7150/thno.4656610.7150/thno.46566 ↗
28. 10.7150/thno.7837010.7150/thno.78370 ↗
29. 10.1126/science.118442910.1126/science.1184429 ↗
30. 10.1080/15548627.2020.177946710.1080/15548627.2020.1779467 ↗
31. 10.1126/sciadv.adf398410.1126/sciadv.adf3984 ↗
32. 10.1016/j.jhep.2021.08.02710.1016/j.jhep.2021.08.027 ↗
33. 10.1002/advs.20230237910.1002/advs.202302379 ↗
34. 10.1096/fj.202101810RR10.1096/fj.202101810RR ↗
35. 10.1007/s00395-023-00996-110.1007/s00395-023-00996-1 ↗
36. 10.1038/s41419-023-05564-y10.1038/s41419-023-05564-y ↗
37. 10.1111/cpr.1299210.1111/cpr.12992 ↗
38. 10.1038/s41392-022-00889-010.1038/s41392-022-00889-0 ↗
39. 10.1038/s12276-023-01069-y10.1038/s12276-023-01069-y ↗
40. 10.1016/j.pharmthera.2021.10801010.1016/j.pharmthera.2021.108010 ↗
41. 10.1016/j.cell.2023.05.00510.1016/j.cell.2023.05.005 ↗
42. 10.1016/j.freeradbiomed.2024.05.03710.1016/j.freeradbiomed.2024.05.037 ↗
43. 10.1016/j.celrep.2021.10985810.1016/j.celrep.2021.109858 ↗
44. 10.1016/j.it.2023.01.00110.1016/j.it.2023.01.001 ↗
45. 10.1038/s41586-021-03875-810.1038/s41586-021-03875-8 ↗
46. 10.1038/s41388-023-02921-110.1038/s41388-023-02921-1 ↗
47. 10.1038/s41392-020-00375-510.1038/s41392-020-00375-5 ↗
48. 10.1038/s41419-023-05702-610.1038/s41419-023-05702-6 ↗
49. 10.1038/s41467-018-02936-310.1038/s41467-018-02936-3 ↗
50. 10.1016/j.ijbiomac.2022.08.01910.1016/j.ijbiomac.2022.08.019 ↗
51. 10.1002/advs.20230353510.1002/advs.202303535 ↗
52. 10.1038/s41467-024-45426-510.1038/s41467-024-45426-5 ↗
53. 10.1038/s41423-023-01065-210.1038/s41423-023-01065-2 ↗
54. 10.1016/j.immuni.2022.10.01410.1016/j.immuni.2022.10.014 ↗
55. 10.1016/j.addr.2021.11400010.1016/j.addr.2021.114000 ↗
56. 10.1126/science.adi641210.1126/science.adi6412 ↗
57. Li S. · JCI Insight · 2021 · 6 · 1993
58. 10.1186/s12974-023-02959-810.1186/s12974-023-02959-8 ↗